It’s Worth A Shot

Patient

Trodevly will become the first target therapy for those suffering from Metastatic Triple Negative Breast Cancer. Though getting the diagnosis may be grave, we set to inspire the patients to hang in there and give it another shot. We may not have won the business but, it was a great exercise to think beyond pink boxing gloves.